NADER EL-MALLAWANY to Young Adult
This is a "connection" page, showing publications NADER EL-MALLAWANY has written about Young Adult.
Connection Strength
0.166
-
Children's Oncology Group's 2023 blueprint for research: Non-Hodgkin lymphoma. Pediatr Blood Cancer. 2023 09; 70 Suppl 6:e30565.
Score: 0.059
-
Clofarabine monotherapy in aggressive, relapsed and refractory Langerhans cell histiocytosis. Br J Haematol. 2024 May; 204(5):1888-1893.
Score: 0.015
-
Diagnosis and management of cutaneous lymphomas and lymphoid proliferations in children, adolescents and young adults (CAYA). Best Pract Res Clin Haematol. 2023 03; 36(1):101448.
Score: 0.014
-
Safety and efficacy of combinatorial therapy utilizing myeloablative conditioning and autologous stem cell transplantation, targeted immunotherapy, and reduced intensity conditioning and allogeneic stem cell transplantation in children, adolescents, and young adults with relapsed/refractory mature B-cell non-Hodgkin lymphoma. Leuk Lymphoma. 2023 01; 64(1):234-237.
Score: 0.014
-
Genetic errors of immunity distinguish pediatric nonmalignant lymphoproliferative disorders. J Allergy Clin Immunol. 2022 02; 149(2):758-766.
Score: 0.013
-
Prospective study of Burkitt lymphoma treatment in adolescents and adults in Malawi. Blood Adv. 2019 02 26; 3(4):612-620.
Score: 0.011
-
Hodgkin lymphoma, HIV, and Epstein-Barr virus in Malawi: Longitudinal results from the Kamuzu Central Hospital Lymphoma study. Pediatr Blood Cancer. 2017 05; 64(5).
Score: 0.009
-
Adolescent and young adult non-Hodgkin lymphoma. Br J Haematol. 2016 05; 173(4):637-50.
Score: 0.009
-
Humoral and cellular immunotherapy in ALL in children, adolescents, and young adults. Clin Lymphoma Myeloma Leuk. 2014 Sep; 14 Suppl:S6-13.
Score: 0.008
-
Adenovirus infection in paediatric allogeneic stem cell transplantation recipients is a major independent factor for significantly increasing the risk of treatment related mortality. Br J Haematol. 2012 Jan; 156(1):99-108.
Score: 0.007
-
Characterization and treatment of chronic active Epstein-Barr virus disease: a 28-year experience in the United States. Blood. 2011 Jun 02; 117(22):5835-49.
Score: 0.006